Stocks News
PacBio Cuts Revenue Outlook as SPRQ-Nx Transition Slows, Targets 2028 Cash-Flow Positivity
Pacific Biosciences of California (NASDAQ:PACB) cut its full-year revenue outlook on Friday after reporting second-quarter revenue of $39 million, as the company...
